The Africa Gazette
SEE OTHER BRANDS

The latest news from Africa

The Africa Gazette: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on The Africa Gazette.

Press releases published on April 1, 2025

Mersana Therapeutics Announces Upcoming Oral Presentation of Emi-Le Clinical Data at European Society for Medical Oncology (ESMO) Breast Cancer 2025 Annual Congress

Mersana Therapeutics Announces Upcoming Oral Presentation of Emi-Le Clinical Data at European Society for Medical Oncology (ESMO) Breast Cancer 2025 Annual Congress

CAMBRIDGE, Mass., April 01, 2025 (GLOBE NEWSWIRE) -- Mersana Therapeutics, Inc. (NASDAQ: MRSN), a clinical-stage biopharmaceutical company focused on discovering and developing a pipeline of antibody-drug conjugates (ADCs) targeting cancers in areas of …

BitMEX Unveils Enhanced BMEX Token Utility with Increased Staking Rewards and Lower Trading Fees

BitMEX Unveils Enhanced BMEX Token Utility with Increased Staking Rewards and Lower Trading Fees

MAHE, Seychelles, April 01, 2025 (GLOBE NEWSWIRE) -- BitMEX, the OG crypto derivatives exchange, today announced significant enhancements to its BMEX Token ecosystem, introducing higher staking rewards, reduced trading fees, and expanded token utility. …

Avalyn Completes Successful Phase 1 Clinical Trials of AP02, its Novel Inhaled Formulation of Nintedanib, Preparing for Phase 2 Development in Idiopathic Pulmonary Fibrosis

Avalyn Completes Successful Phase 1 Clinical Trials of AP02, its Novel Inhaled Formulation of Nintedanib, Preparing for Phase 2 Development in Idiopathic Pulmonary Fibrosis

Topline data from the single- and multiple-ascending dose studies confirmed safety and favorable tolerability profile of AP02 at all dose levels Full safety, tolerability, and pharmacokinetics data to be presented at the American Thoracic Society 2025 …

Qualigen seeks to enter the $10 Billion CABG market with non-binding MOU to acquire Marizyme

Qualigen seeks to enter the $10 Billion CABG market with non-binding MOU to acquire Marizyme

CARLSBAD, Calif., April 01, 2025 (GLOBE NEWSWIRE) -- Qualigen Therapeutics, Inc. (NASDAQ: QLGN) (the “Company”) announced today they have entered a non-binding Memorandum of Understanding (MOU) to acquire Marizyme (OTC: MRZM). Qualigen and Marizyme have …

Skyharbour Partner Company Terra Clean Energy Completes Winter Drill Program with Encouraging Results and Prepares a Significant Summer Drill Program at the South Falcon East Uranium Project

Skyharbour Partner Company Terra Clean Energy Completes Winter Drill Program with Encouraging Results and Prepares a Significant Summer Drill Program at the South Falcon East Uranium Project

Vancouver, BC, April 01, 2025 (GLOBE NEWSWIRE) -- Skyharbour Resources Ltd. (TSX-V: SYH) (OTCQX: SYHBF) (Frankfurt: SC1P) (“Skyharbour” or the “Company”) is pleased to announce that partner company Terra Clean Energy Corp. (“Terra”, previously Tisdale …

Context Therapeutics to Participate in Upcoming Investor Conferences

Context Therapeutics to Participate in Upcoming Investor Conferences

PHILADELPHIA, April 01, 2025 (GLOBE NEWSWIRE) -- Context Therapeutics Inc. (“Context” or the “Company”) (Nasdaq: CNTX), a clinical-stage biopharmaceutical company advancing T cell engaging bispecific antibodies for solid tumors, today announced its …

Endeavour Silver Announces Expansion into Peru with Acquisition of Minera Kolpa, Copper Stream and Bought Deal Financing

Endeavour Silver Announces Expansion into Peru with Acquisition of Minera Kolpa, Copper Stream and Bought Deal Financing

The Base Shelf Prospectus is accessible, and the Prospectus Supplement will be accessible within two business days, through SEDAR+ All dollar amounts are stated in United States (U.S.) Dollars unless otherwise noted. VANCOUVER, British Columbia, April 01, …

Apellis Announces FDA Acceptance and Priority Review of the Supplemental New Drug Application for EMPAVELI® (pegcetacoplan) for C3G and Primary IC-MPGN

Apellis Announces FDA Acceptance and Priority Review of the Supplemental New Drug Application for EMPAVELI® (pegcetacoplan) for C3G and Primary IC-MPGN

PDUFA target action date is July 28, 2025 WALTHAM, Mass., April 01, 2025 (GLOBE NEWSWIRE) -- Apellis Pharmaceuticals, Inc. (Nasdaq: APLS) today announced that the U.S. Food and Drug Administration (FDA) has accepted and granted Priority Review designation …

Ventyx Biosciences Expands SAB with Renowned NLRP3 Experts and Prominent Neurodegenerative and Cardiometabolic Disease Specialists

Ventyx Biosciences Expands SAB with Renowned NLRP3 Experts and Prominent Neurodegenerative and Cardiometabolic Disease Specialists

Appointment of seven recognized experts is validating for Ventyx’s NLRP3 Program -- AD/PD™ 2025 provides helpful insights on potential next steps in Parkinson’s disease SAN DIEGO, April 01, 2025 (GLOBE NEWSWIRE) -- Ventyx Biosciences, Inc. (Nasdaq: VTYX) …

Rio Silver Pivots to High-Grade Silver Exploration / Exploitation - Announces Executive Changes

Rio Silver Pivots to High-Grade Silver Exploration / Exploitation - Announces Executive Changes

VANCOUVER, British Columbia, April 01, 2025 (GLOBE NEWSWIRE) -- Rio Silver Inc. (“Rio Silver” or the “Company”) (TSX.V: RYO) (OTC: RYOOF) announces that it has appointed Eric H. Hinton, P.Eng., FCIM, to the Advisory Board. Eric H. Hinton, P.Eng., FCIM, has …

Medicenna to Present at Jones Healthcare and Technology Innovation Conference

Medicenna to Present at Jones Healthcare and Technology Innovation Conference

TORONTO and HOUSTON, April 01, 2025 (GLOBE NEWSWIRE) -- Medicenna Therapeutics Corp. (“Medicenna” or the “Company”) (TSX: MDNA, OTCQX: MDNAF), a clinical-stage immunotherapy company focused on the development of Superkines targeting cancer and autoimmune …

Codexis Appoints Cynthia Collins to Board of Directors

Codexis Appoints Cynthia Collins to Board of Directors

REDWOOD CITY, Calif., April 01, 2025 (GLOBE NEWSWIRE) -- Codexis, Inc. (NASDAQ: CDXS), a leading provider of enzymatic solutions for efficient and scalable therapeutics manufacturing, today announced the appointment of Cynthia Collins to the Company’s …

Pharvaris Announces Orphan Designation Granted to Deucrictibant by the European Commission

Pharvaris Announces Orphan Designation Granted to Deucrictibant by the European Commission

ZUG, Switzerland, April 01, 2025 (GLOBE NEWSWIRE) -- Pharvaris (Nasdaq: PHVS), a late-stage biopharmaceutical company developing novel, oral bradykinin B2 receptor antagonists to help address unmet needs of those living with bradykinin-mediated diseases …

Newcore Gold Drilling Intersects 0.73 g/t Gold over 68.0 Metres and 1.39 g/t Gold over 24.0 metres at the Enchi Gold Project, Ghana

Newcore Gold Drilling Intersects 0.73 g/t Gold over 68.0 Metres and 1.39 g/t Gold over 24.0 metres at the Enchi Gold Project, Ghana

VANCOUVER, British Columbia, April 01, 2025 (GLOBE NEWSWIRE) -- Newcore Gold Ltd. ("Newcore" or the "Company") (TSX-V: NCAU, OTCQX: NCAUF) is pleased to announce additional drill results from the 35,000-metre drill program underway at the Company’s 100% …

Verano Expands Connecticut Footprint with Opening of Zen Leaf Ashford, Company’s Sixth Retail Location and Closest Cannabis Dispensary1 to University of Connecticut

Verano Expands Connecticut Footprint with Opening of Zen Leaf Ashford, Company’s Sixth Retail Location and Closest Cannabis Dispensary1 to University of Connecticut

Zen Leaf Ashford will feature exclusive 20% everyday “Higher Education” UConn student discount and celebrate Husky wins with special deals for victories in multiple sports Zen Leaf Ashford, located at 55 Nott Hwy, is the closest dispensary to the …

ITM Appoints Dr. Celine Wilke as Chief Medical Officer

ITM Appoints Dr. Celine Wilke as Chief Medical Officer

Experienced leader in radiopharmaceutical drug development, regulatory, and clinical strategies will advance ITM’s broad pipeline and clinical development strategy Garching / Munich, Germany, April 01, 2025 – ITM Isotope Technologies Munich SE (ITM), a …

Oculis to Host In-Person and Virtual R&D Day on Key Business Updates and the Development Plans for Privosegtor (OCS-05) in Acute Optic Neuritis and Beyond

Oculis to Host In-Person and Virtual R&D Day on Key Business Updates and the Development Plans for Privosegtor (OCS-05) in Acute Optic Neuritis and Beyond

ZUG, Switzerland, April 01, 2025 (GLOBE NEWSWIRE) -- Oculis Holding AG (Nasdaq: OCS / XICE: OCS) (“Oculis” or the “Company"), a global biopharmaceutical company focused on innovations addressing ophthalmic and neuro-ophthalmic diseases with significant …

Nxera Pharma Announces Appointments to its Executive Leadership Team

Nxera Pharma Announces Appointments to its Executive Leadership Team

Mr. Kiyoshi Kaneko appointed as Chief Commercial Officer, and Ms. Mariko Nakafuji promoted to Chief Legal Officer Tokyo, Japan and Cambridge, UK, 1 April 2025 – Nxera Pharma Co., Ltd. (“Nxera” or “the Company”; TSE 4565) today announces two new …

Aura Reports Updated Mineral Reserves And Mineral Resources For The Year-Ended 2024, Highlighting Ongoing Exploration And Strong Growth Trajectory

Aura Reports Updated Mineral Reserves And Mineral Resources For The Year-Ended 2024, Highlighting Ongoing Exploration And Strong Growth Trajectory

ROAD TOWN, British Virgin Islands, April 01, 2025 (GLOBE NEWSWIRE) -- Aura Minerals Inc. (TSX: ORA) (B3: AURA33) (OTCQX: ORAAF) (“Aura” or the “Company”) is pleased to report updated Mineral Reserves and Mineral Resources (“MRMR”) for its four operating …

Aura Minerals Updates Aranzazu, Almas and Minosa NI 43-101 Technical Reports

Aura Minerals Updates Aranzazu, Almas and Minosa NI 43-101 Technical Reports

ROAD TOWN, British Virgin Islands, March 31, 2025 (GLOBE NEWSWIRE) -- Aura Minerals Inc. (TSX: ORA) (B3: AURA33) (OTCQX: ORAAF) (“Aura” or the “Company”) is pleased to announce that it has filed updated technical reports (the “Reports”) for its Aranzazu, …

Share us

on your social networks:
AGPs

Get the latest news on this topic.

SIGN UP FOR FREE TODAY

No Thanks

By signing to this email alert, you
agree to our Terms of Service